Pre-dilatation balloon aortic valvuloplasty may reduce post-dilatation needs in patients with aortic stenosisNew data clarifies risks of balloon techniques for heart valves

Frontiers in Medicine Published August 26, 2026 DOI ↗ Editorial oversight: Dr. Amelia Tan, PhD · Internal Medicine & Chronic Disease

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway

Consider pre-dilatation to potentially reduce post-dilatation needs without increasing adverse events in aortic stenosis.

The study examined clinical outcomes in patients undergoing transcatheter aortic valve implantation using self-expanding valves. The analysis compared pre-dilatation balloon aortic valvuloplasty against direct implantation and assessed the effects of post-dilatation versus leaving valves as deployed. Outcomes included mortality, stroke, pacemaker implantation, and paravalvular leak.

Results indicated that pre-dilatation was associated with a reduced need for post-dilatation compared to direct implantation. However, no significant differences were found regarding mortality, stroke, or pacemaker implantation when comparing pre-dilatation to direct implantation. In contrast, observational data regarding post-dilatation showed higher rates of mortality and paravalvular leaks; however, the authors noted these findings are likely due to confounding by indication rather than a causal effect.

The study highlights that while pre-dilatation appears safe and may streamline the procedure by reducing post-dilatation requirements, the data regarding post-dilatation outcomes must be interpreted with caution. Clinicians should consider the role of pre-dilatation as a potential strategy to simplify the implantation process for self-expanding valves.

When patients undergo a procedure to replace a narrowed heart valve, doctors sometimes use balloons to widen the area. This study looked at over 30,000 patients to see how these different balloon techniques affected safety and success. The goal was to find out which methods provide the best protection for the patient.

Researchers found that performing a balloon expansion before the valve is placed (PRE-BAV) did not lead to more strokes or heart issues compared to direct implantation. However, when doctors used a balloon after the valve was already in place (POST-DIL), the data showed higher rates of 30-day mortality and serious leaks around the valve. These risks were also linked to more frequent surgeries.

It is important to note that the risks seen with the post-procedure technique might be due to how doctors choose which patients need it, rather than the balloon itself causing the problem. Because these results come from observational data, the link between the procedure and the risk is not certain. Talk to your doctor about which specific approach is safest for your heart.

What this means for you:

Pre-procedure balloon expansion appears safe, but post-procedure expansion may show higher risks in some cases.

Common questions

Is the pre-procedure balloon expansion safe?

Yes. The study found that performing a balloon expansion before the valve is placed (PRE-BAV) was not associated with an increased risk of death, stroke, or needing a permanent pacemaker compared to direct implantation.

What are the risks of post-procedure balloon dilation?

In observational studies, using a balloon after the valve is placed (POST-DIL) was linked to higher 30-day mortality and more frequent leaks around the valve. However, these results may be due to which patients were chosen for the procedure.

How does this affect heart valve surgery outcomes?

While pre-procedure expansion might reduce the need for later adjustments, post-procedure expansion was linked to more frequent surgical conversions. You should discuss these specific techniques with your cardiologist to understand what is best for you.

Study Details

Study typeMeta analysis

EvidenceLevel 1

PublishedAug 2026

View Original Abstract ↓

IntroductionPre-dilatation balloon aortic valvuloplasty (PRE-BAV) and post-dilatation (POST-DIL) are commonly used during transcatheter aortic valve implantation with self-expanding valves (SEV-TAVI) to facilitate device delivery and optimize valve expansion, but both may increase procedural complications.MethodsWe conducted a systematic review and meta-analysis to evaluate outcomes associated with PRE-BAV and POST-DIL compared with direct implantation (DIRECT) and valves left as deployed (AS-DEPLOYED), respectively. Eleven studies (nine observational, two randomised; 24,143 patients) were included for PRE-BAV and five observational studies (7,526 patients) for POST-DIL. Key outcomes included mortality, stroke, permanent pacemaker implantation, and moderate or greater paravalvular leak (PVL2+). Random-effects meta-analyses with Hartung–Knapp–Sidik–Jonkman adjustment were used to estimate pooled odds ratios (ORs) with 95% confidence intervals (CIs).ResultsCompared with DIRECT, PRE-BAV was not associated with differences in mortality, stroke, pacemaker implantation, or PVL2+, but randomised data showed a reduced need for POST-DIL (OR 0.43; 95% CI 0.24–0.74). Compared with AS-DEPLOYED, observational series suggested that POST-DIL was linked to higher 30-day mortality (OR 1.39; 95% CI 1.18–1.63), increased PVL2+ (OR 3.76; 95% CI 2.13–6.63), and more frequent surgical conversion (OR 1.22; 95% CI 1.06–1.41), with no differences in stroke or pacemaker implantation.DiscussionPRE-BAV was not associated with increased adverse outcomes and may reduce the need for post-dilatation, whereas the adverse outcomes observed with POST-DIL in observational studies are most likely explained by confounding by indication rather than a causal effect. Further adequately powered randomised trials are needed to define the optimal balloon dilatation strategy in SEV-TAVI.Systematic Review Registrationhttps://www.crd.york.ac.uk/PROSPERO/view/CRD42024610604.

Pre-dilatation balloon aortic valvuloplasty may reduce post-dilatation needs in patients with aortic stenosisNew data clarifies risks of balloon techniques for heart valves

Common questions

Study Details

Dual antiplatelet therapy reduces all-cause death but not MACE or myocardial infarction in MINOCA

Dual antiplatelet therapy shows survival benefits for MINOCA patients

Clinical research that matters. Delivered to your inbox.

Pre-dilatation balloon aortic valvuloplasty may reduce post-dilatation needs in patients with aortic stenosisNew data clarifies risks of balloon techniques for heart valves

Common questions

More on Aortic Stenosis

Study Details

Dual antiplatelet therapy reduces all-cause death but not MACE or myocardial infarction in MINOCA

Dual antiplatelet therapy shows survival benefits for MINOCA patients

Clinical research that matters. Delivered to your inbox.

Related in Cardiology

From Other Specialties